Recursion Pharmaceuticals-a Stock Performance
as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
$4.4$4.64
4.76%
Downside
0.43%
Upside
52 Week's Low
52 Week's High
$3.79$12.3617.97%
Downside
167.53%
Upside
Recursion Pharmaceuticals-a share price movements today
- Previous Close
- $4.41
- Open
- $4.48
- Volume
- 10.4M
- Day's Low - High
- $4.4 - $4.64
- 52 Week Low - High
- $3.79 - $12.36
Recursion Pharmaceuticals-a Historical Returns
- 1 Month Return
- -21.12 %
- 3 Month Return
- -1.49 %
- 1 Year Return
- -34.51 %
- 3 Year Return
- -47.68 %
- 5 Year Return
- 0 %
Recursion Pharmaceuticals-a Stock Fundamentals & Key Indicators
Check Recursion Pharmaceuticals-a market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.3B
EPS (TTM)
-1.6064
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.41
Industry PE ratio
8.214070796460177
PEG Ratio
0EBITDA
-640.5M
Revenue (TTM)
43.7M
Profit Margin
0.00%
Return On Equity TTM
-91.07%
Recursion Pharmaceuticals-a Stock Valuation
Track how Recursion Pharmaceuticals-a P/E has moved over time to understand its valuation trends.
Recursion Pharmaceuticals-a in the last 5 years
Lowest (-17.36x)
June 30, 2021
Today (-5.41x)
November 29, 2025
Industry (8.21x)
November 29, 2025
Highest (-2.76x)
June 30, 2025
Today’s Price to Earnings Ratio: -5.41x
Recursion Pharmaceuticals-a vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Recursion Pharmaceuticals-a with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.3B | NA | -5.41 | 0.00% | |
| BUY | $44.3B | 422.04% | -16.34 | -264.83% | |
| BUY | $58.8B | 247.47% | 1435.87 | 1.36% | |
| BUY | $110.8B | 91.26% | 30.39 | 31.35% | |
| BUY | $83.2B | 51.77% | 18.8 | 32.13% |
Stock Returns calculator for Recursion Pharmaceuticals-a Stock including INR - Dollar returns
The Recursion Pharmaceuticals-a stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Recursion Pharmaceuticals-a investment value today
Current value as on today
₹70,753
Returns
Returns from Recursion Pharmaceuticals-a Stock
Dollar Returns*
₹5,406 (+5.41%)
Analyst Recommendation on Recursion Pharmaceuticals-a Stock
Based on 13 analysts
53.85%
Buy
46.15%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Recursion Pharmaceuticals-a. Average target price of $6.33
Recursion Pharmaceuticals-a Share Price Target
Get share price movements and forecasts by analysts on Recursion Pharmaceuticals-a.
What analysts predicted
27.01%UPSIDE
Target Price
$6.33
Current Price
$4.62
Analyzed by
13 Analysts
Target
$6.33
Recursion Pharmaceuticals-a target price $6.33, a slight upside of 27.01% compared to current price of $4.62. According to 13 analysts rating.
Recursion Pharmaceuticals-a Stock’s Investor Sentiment and Interest
Investment in Recursion Pharmaceuticals-a Shares on INDmoney has dropped by -14.79% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Recursion Pharmaceuticals-a Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:29% versus previous 30 day period
Recursion Pharmaceuticals-a Quarterly Profit & Loss
All numbers in Millions USD
Recursion Pharmaceuticals-a Annual Profit & Loss
All numbers in Millions USD
Recursion Pharmaceuticals-a Quarterly Cash Flow
All numbers in Millions USD
Recursion Pharmaceuticals-a Annual Cash Flow
All numbers in Millions USD
Recursion Pharmaceuticals-a News & Key Events
Today's Timeline - 27 October
Mon, 11:35 AM
-Recursion Pharmaceuticals updates on merger with Exscientia and trial progress, boosting investor confidence despite previous negative returns.
Tue, 02:37 AM
-Recursion Pharmaceuticals announces ongoing clinical study for REC-1245 targeting advanced cancers, with recruitment still active.
Tue, 03:40 AM
-Recursion Pharmaceuticals updates on REC-4881 study for Familial Adenomatous Polyposis, indicating ongoing recruitment and potential market impact.
Insights on Recursion Pharmaceuticals-a
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, RXRX stock has moved up by 11.0%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -202.48M → -162.25M (in $), with an average increase of 11.9% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 1023.7% return, outperforming this stock by 1074.4%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 210.9%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 19.10M → 5.17M (in $), with an average decrease of 72.9% per quarter
About Recursion Pharmaceuticals-a
| Organisation | Recursion Pharmaceuticals-a |
| Headquarters | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
| Industry | Services |
| CEO | Dr. Christopher C. Gibson Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Recursion Pharmaceuticals-a
Name | Title |
|---|---|
Dr. Christopher C. Gibson Ph.D. | Co-Founder, CEO & Director |
Dr. Najat Khan Ph.D. | Chief R&D Officer, Chief Commercial Officer and Director |
Ms. Kristen Rushton M.B.A. | Chief Operating Officer |
Dr. David Hallett Ph.D. | Chief Scientific Officer |
Mr. Nathan Hatfield J.D., M.B.A. | Chief Legal Officer & Corporate Secretary |
Ms. Erica Fox | Chief People and Impact Officer |
Mr. Ben R. Taylor | CFO & President of Recursion UK |
Dr. David J. Mauro M.D., Ph.D. | Chief Medical Officer |
Mr. Benjamin Mabey M.S. | Chief Technology Officer |
Mr. Matthew Kinn M.B.A. | Chief Business Officer |
FAQs
What is Recursion Pharmaceuticals-a share price today?
Recursion Pharmaceuticals-a share price today is $4.62 as on at the close of the market. Recursion Pharmaceuticals-a share today touched a day high of $4.64 and a low of $4.4.
What is the 52 week high and 52 week low for Recursion Pharmaceuticals-a share?
Recursion Pharmaceuticals-a share touched a 52 week high of $12.36 on and a 52 week low of $3.79 on . Recursion Pharmaceuticals-a stock price today i.e. is closed at $4.62,which is 62.62% down from its 52 week high and 21.90% up from its 52 week low.
What is Recursion Pharmaceuticals-a's market capitalisation today?
Recursion Pharmaceuticals-a market capitalisation is $0.00T as on .
How to invest in Recursion Pharmaceuticals-a Stock (RXRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Recursion Pharmaceuticals-a on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Recursion Pharmaceuticals-a Shares that will get you 0.3247 shares as per Recursion Pharmaceuticals-a share price of $4.62 per share as on November 28, 2025 at 11:29 pm IST.
What is the minimum amount required to buy Recursion Pharmaceuticals-a Stock (RXRX) from India?
Indian investors can start investing in Recursion Pharmaceuticals-a (RXRX) shares with as little as ₹89.332 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.32 in Recursion Pharmaceuticals-a stock (as per the Rupee-Dollar exchange rate as on ).
Based on Recursion Pharmaceuticals-a share’s latest price of $4.62 as on November 28, 2025 at 11:29 pm IST, you will get 2.1645 shares of Recursion Pharmaceuticals-a. Learn more about
fractional shares .